ArchiMed completes take-private deal of Natus for $1.1bn

As a result of the closing, Natus will no longer trade on the NASDAQ.

  • According to terms of the deal, Natus shareholders will receive $33.50 in cash
  • Headquartered in Middleton, Wisconsin, Natus is a provider of neurodiagnostic devices
  • It was founded in 1987

ArchiMed has closed its take-private deal of Natus Medical Incorporated for $1.1 billion. According to terms of the deal, Natus shareholders will receive $33.50

Share this